Inventor · disambiguated record
Ryuji Hashimoto
Also filed as: HASHIMOTO RYUJI
12 granted patents·7 pending applications·21 citations·filing 1997–2025
87Inventor score
Files withDAIICHI SANKYO CO LTD10UNIV MIE3DAIICHI SEIYAKU CO2PIERIS PHARMACEUTICALS GMBH2MACHINAGA NOBUO1
Top patents by PatentIndex Score
19 records- 0187US10550154B2Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2013·Granted Feb 4, 2020·5 cites·12 claims
- 0287US2025042947A1Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 0383US11319345B2Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2020·Granted May 3, 2022·1 cites·16 claims
- 0482US10400016B2Proteins specific for calcitonin gene-related peptidePIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Sep 3, 2019·4 cites·25 claims
- 0578US2024294610A1Peptide for treating age-related macular degenerationDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 0677US2022372076A1Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2022·Application pending·0 cites
- 0776US11952423B2Bispecific antibodyUNIV MIE·Filed 2023·Granted Apr 9, 2024·0 cites·28 claims
- 0875US12043658B2Conjugate comprising an active MMP-9-binding peptideDAIICHI SANKYO CO LTD·Filed 2022·Granted Jul 23, 2024·0 cites·18 claims
- 0975US11034737B2Proteins specific for calcitonin gene-related peptidePIERIS PHARMACEUTICALS GMBH·Filed 2019·Granted Jun 15, 2021·1 cites·17 claims
- 1074US11926655B2Active MMP9-binding peptideDAIICHI SANKYO CO LTD·Filed 2018·Granted Mar 12, 2024·1 cites·9 claims
- 1172US2025282889A1Bispecific antibodyUNIV MIE·Filed 2025·Application pending·0 cites
- 1269US9150629B2Human tear lipocalins which bind PCSK9 and methods of use thereofPIERIS AG·Filed 2014·Granted Oct 6, 2015·1 cites·56 claims
- 1366US12344674B2Bispecific antibodyUNIV MIE·Filed 2021·Granted Jul 1, 2025·0 cites·18 claims
- 1461US9120835B2Phosphoric acid ester derivativesMACHINAGA NOBUO·Filed 2012·Granted Sep 1, 2015·1 cites·16 claims
- 1554US6428781B1Composition of an endogenous insulin-like growth factor-II derivativeDAIICHI SEIYAKU CO·Filed 1997·Granted Aug 6, 2002·7 cites·7 claims
- 1654US2020377573A1Peptide for treating age-related macular degenerationDAIICHI SANKYO CO LTD·Filed 2017·Application pending·0 cites
- 1753US2003170240A1Composition of an endogenous insulin-like growth factor-II derivativeDAIICHI SEIYAKU CO·Filed 2002·Application pending·0 cites
- 1850US9598476B2Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9DAIICHI SANKYO CO LTD·Filed 2015·Granted Mar 21, 2017·0 cites·51 claims
- 1950US2017173112A1Novel binding proteins for pcsk9DAIICHI SANKYO CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryuji Hashimoto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →